Breaking News Instant updates and real-time market news.

BABA

Alibaba

$144.86

-4.06 (-2.73%)

, SAP

SAP

$108.33

0.72 (0.67%)

19:27
11/11/18
11/11
19:27
11/11/18
19:27

Fly Intel: Top five weekend stock stories

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Alibaba (BABA) announced that it generated $30.8B of gross merchandise volume on November 11, 2018, an increase of 27% compared to 2017. However, according to Reuters, while Alibaba cashed a record in sales on Sunday during its 24-hour online retail frenzy Singles' Day, the event's annual growth dropped to its slowest-ever rate, falling from 39% to 27%, at the low end of analyst estimates. 2. SAP (SAP) and Qualtrics International (XM) announced they have entered into a definitive agreement under which SAP SE intends to acquire Qualtrics. Under the terms of the agreement, SAP will acquire all outstanding shares of Qualtrics for $8B in cash. SAP has secured financing in the amount of EUR$7B to cover purchase price and acquisition-related costs. The purchase price includes unvested employee incentive compensation and cash on the balance sheet at close. Subject to customary closing conditions and attainment of regulatory clearances, the acquisition is expected to close in the first half of 2019. 3. Dollar Tree (DLTR) has successfully dangled deals in front of consumers for years, but its "magic touch" has faded this year, putting the company's stock in the bargain bin, Avi Salzman wrote in this week's edition of Barron's. Dollar Tree's woes stem from its decision to buy Family Dollar three years ago, with its results deteriorating since and investors punishing the stock, the publication noted. 4. Christmas came early, with Comcast (CMCSA) subsidiary Universal's "Dr. Seuss' The Grinch" opening to $66M from 4,414 North American theaters. The movie, which is the first family event film of the year-end corridor, earned an A- CinemaScore. 5. Boeing (BA), Lockheed Martin (LMT), and General Dynamics (GD) saw positive mentions in Barron's.

BABA

Alibaba

$144.86

-4.06 (-2.73%)

SAP

SAP

$108.33

0.72 (0.67%)

XM

Qualtrics

$0.00

(0.00%)

DLTR

Dollar Tree

$86.36

-1.48 (-1.68%)

CMCSA

Comcast

$38.34

0.03 (0.08%)

CMCSK

Comcast

$0.00

(0.00%)

BA

Boeing

$369.34

-1.46 (-0.39%)

LMT

Lockheed Martin

$313.24

4.73 (1.53%)

GD

General Dynamics

$184.53

-0.06 (-0.03%)

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 14

    Nov

  • 15

    Nov

  • 26

    Nov

BABA Alibaba
$144.86

-4.06 (-2.73%)

11/05/18
UBSW
11/05/18
NO CHANGE
Target $200
UBSW
Buy
Alibaba price target lowered to $200 from $220 at UBS
UBS analyst Jerry Liu lowered his price target on Alibaba to $200 from $220 following Q2 results. He said although he has to adjust his estimates due to macro events, he believes the long-term story remains intact. He noted the Taobao app is seeing higher user engagement, which should result in higher sales, and also noted its new retail initiatives are gaining traction. Liu reiterated his Buy rating on Alibaba shares.
11/05/18
KEYB
11/05/18
NO CHANGE
Target $203
KEYB
Overweight
Alibaba price target lowered to $203 from $215 at KeyBanc
KeyBanc analyst Hans Chung lowered his price target for Alibaba to $203 from $215 after the company lowered FY19 guidance due to uncertainty around the macroeconomy and near-term impact by the transition to recommendation feeds. The analyst believes these two factors have concerned investors, while the model could now be largely de-risked. Chung expects incremental monetization opportunity in the long-term when Alibaba normalizes the monetization level on feeds. He still views it as more immune to macro risk than others given share gains in the offline space and business diversification. The analyst reiterates an Overweight rating on the shares.
11/05/18
RHCO
11/05/18
NO CHANGE
Target $180
RHCO
Buy
Alibaba price target lowered to $180 from $195 at SunTrust
SunTrust analyst Youssef Squali lowered his price target on Alibaba to $180, citing a rising macro uncertainty and the management's decision to postpone the "monetization of incremental inventory". The analyst keeps his Buy rating on Alibaba shares longer term based on the company's "strong" core commerce growth, market share gains, and stable margins deployed to fund new initiative. Squali notes that Alibaba should outperform thanks to China's on-going consumption upgrade and dominant online position.
11/06/18
OPCO
11/06/18
NO CHANGE
Target $185
OPCO
Outperform
Alibaba price target lowered to $185 from $210 at Oppenheimer
Oppenheimer analyst Jason Helfstein lowered his price target for Alibaba to $185 from $210 on weaker Q2 results and reduced FY19 revenue guidance. The analyst reiterates an Outperform rating on the shares.
SAP SAP
$108.33

0.72 (0.67%)

11/06/18
JMPS
11/06/18
INITIATION
Target $29
JMPS
Outperform
Anaplan initiated with an Outperform at JMP Securities
JMP Securities analyst Patrick Walravens initiated Anaplan (PLAN) with an Outperform rating and $29 price target, stating that he believes it is well-positioned to increase its share of the worldwide performance management and analytic applications software market from about 1% today to about 3% in 2022. He sees the company being able to take share from Excel-based solutions, homegrown products, and incumbents such as Oracle (ORCL), IBM (IBM), and SAP (SAP), Walravens added.
10/22/18
10/22/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Intel (INTC) upgraded to Buy from Neutral at Nomura Instinet with analyst Romit Shah saying he believes Intel is a buy at current share levels. 2. AT&T (T) upgraded to Buy from Neutral at Tigress Financial with analyst Ivan Feinseth saying the upcoming launch of its high-speed 5G wireless communication network and the integration of Time Warner's content "creates a significant investment opportunity." 3. M&T Bank (MTB) upgraded to Overweight from Neutral at Piper Jaffray with analyst Kevin Barker saying this quarter, M&T's deposit base remained steady, its loan/deposit ratio declined and management felt confident the ratio would remain in the 95%-100% range for the foreseeable future. 4. Chipotle (CMG) upgraded to Outperform from Sector Perform at RBC Capital with analyst David Palmer saying while Q3 earnings may be "lackluster," he expects comps to improve from 4% to 6% through the second half of FY19 and raises his FY20 EPS vie to $16.30 from $15.86 on implied 3-turn multiple increase to 31-times forward earnings. 5. SAP (SAP) upgraded to Buy from Neutral at UBS with analyst Michael Briest saying the company deserves credit for sustaining 6%-10% underlying sales growth over the past 12 quarters, with "impressive" cloud growth at scale. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/22/18
UBSW
10/22/18
UPGRADE
UBSW
Buy
SAP upgraded to Buy from Neutral at UBS
UBS analyst Michael Briest upgraded SAP to Buy and raised his price target for the shares to EUR 110 from EUR 108 following last week's Q3 results. The company deserves credit for sustaining 6%-10% underlying sales growth over the past 12 quarters, with "impressive" cloud growth at scale, Briest tells investors in a research note titled "Reality checked. Upgrade to Buy." Further, the analyst sees signs that SAP's cash flow will improve in 2019 as spending growth moderates.
10/17/18
BERN
10/17/18
UPGRADE
BERN
Outperform
Workday upgraded to Outperform on long-term growth at Bernstein
As previously reported, Bernstein analyst Mark Moerdler upgraded Workday (WDAY) to Outperform from Market Perform. After looking into the ERP market in his recent multi-part ERP Primer series, the analyst has determined that even if the ERP market moves reasonably slowly to the Cloud, it is large enough and the fact there are only a few vendors with a competitive SaaS solution should allow Workday to continue to gain share. In fact, Moerdler believes that the market is large enough that even if Workday does not take customers from Oracle (ORCL) or SAP (SAP), it can still grow its subscription revenue with a 24%-36% 5-year CAGR through 2022.
XM Qualtrics
$0.00

(0.00%)

DLTR Dollar Tree
$86.36

-1.48 (-1.68%)

10/17/18
WELS
10/17/18
NO CHANGE
Target $104
WELS
Outperform
Survey shows pressing need of ramp investment or sell Family Dollar, says Wells Fargo
Wells Fargo analyst Edward Kelly notes The New York Post reported that Carl Icahn is building a significant stake in Dollar Tree (DLTR), which could be clear opportunity to unlock value. The analyst believes Dollar Tree remains materially undervalued, but is in desperate need of change. Family Dollar looks to be suffering from underinvestment and execution issues, and his new proprietary work suggests there is a pressing need to either ramp investment to better compete with Dollar General (DG) or sell. The analyst argues that the core is a good business, but breaking the buck represents a compelling opportunity to extend growth and enhance profitability. He reiterates an Outperform rating and $104 price target on Dollar Tree's shares.
10/17/18
KEYB
10/17/18
NO CHANGE
Target $108
KEYB
Overweight
Dollar Tree price target lowered to $108 from $115 at KeyBanc
KeyBanc analyst Bradley Thomas lowered his price target for Dollar Tree to $108 from $115, while reiterating an Overweight rating on the stock. The analyst notes that the NY Post reported that Carl Icahn is building a stake in Dollar Tree, and argues that an activist stake raises potential for a Family Dollar divestiture. Overall, Thomas believes Family Dollar trends may still be challenged and sees China tariffs as a threat to 2019 margins, but things a good degree of these risks are priced in at current levels.
10/16/18
BUCK
10/16/18
NO CHANGE
Target $92
BUCK
Neutral
Buckingham reiterates Neutral on Dollar Tree as potential activism heightens
Buckingham analyst Bob Summers reiterates a Neutral rating and $92 price target on Dollar Tree shares as speculation surrounding potential activism heightens as an unconfirmed NY Post article claims Carl Icahn has established a position in the name. The NY Post article represents the pinnacle of the "activism" discussions recently surrounding the stock, the analyst notes, highlighting that that he has no direct or indirect knowledge of Carl Icahn building a position. Nonetheless, if he had to hypothesize about potential suggestions made to management, it would include spinning Family Dollar, aggressively purge the under-performing stores, and accelerate annual renovations. While there very well may be a consensus on how to go about improving the store base, Summers believes management does not have the same sense of panic or urgency.
10/16/18
LOOP
10/16/18
NO CHANGE
Target $107
LOOP
Buy
Reported Icahn stake in Dollar Tree a positive development, says Loop Capital
Loop Capital analyst Anthony Chukumba views the New York Post's report of Carl Icahn taking a "significant" stake in Dollar Tree (DLTR) as "unsurprising" and a "positive development." Icahn previously acquired a stake in Family Dollar, pressured management to seek a buyer, and reportedly made a $200M profit on his investment when the company was acquired by Dollar Tree in 2015 for $8.5B, Chukumba tells investors in a research note. The analyst believes it was just a matter of time before an activist became involved given the Family Dollar segment's continued struggles while the core Dollar Tree segment "remains one of the best performers in deep discount retailing." He thinks Icahn is likely to pressure Dollar Tree management to quickly improve the performance of Family Dollar significantly or sell the division. There would be several interested parties if Dollar Tree put Family Dollar on the block, including Dollar General (DG), Amazon.com (AMZN) and private equity firms, Chukumba predicts. He reiterates a Buy rating on Dollar Tree shares with a $107 price target. The stock in afternoon trading is up 6.5%, or $5.23, to $86.20 following the New York Post's report.
CMCSA Comcast
$38.34

0.03 (0.08%)

11/08/18
11/08/18
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Stanley Black & Decker (SWK) initiated with a Hold at Deutsche Bank. 2. Comcast (CMCSA) resumed with an Overweight at Morgan Stanley while Amarin (AMRN) and Immunomedics (IMMU) were assumed with a Buy at the firm. 3. Broadcom (AVGO) resumed with a Buy at Deutsche Bank and reinstated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/08/18
MSCO
11/08/18
INITIATION
Target $46
MSCO
Overweight
Comcast resumed with an Overweight at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne resumed coverage of Comcast (CMCSA) with an Overweight rating and $46 price target, stating that while the burden of proof is on the company to successfully execute its Sky (SKYAY) acquisition, the stock's multiple has compressed even though his expectation for Comcast's consolidated growth outlook has not materially changed. In the near-term, Sky will be accretive to that growth rate, Swinburne added. He also said that Comcast "remains first and foremost a US cable business," and he sees broadband as a secular growth driver with a long-term runway.
10/30/18
MSCO
10/30/18
NO CHANGE
Target $95
MSCO
Overweight
WWE shares 'on sale' after pullback, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne noted that WWE (WWE) shares are down by over 30% this month, which he sees as a "rare opportunity" to buy shares of a company that he sees having both highly visible earnings growth and growing intellectual property value. He attributes the rapid selloff primarily to a broader market rotation out of risk assets due to rising interest rates and concerns over achieving long-term growth, but he thinks this "does not make sense" given that WWE's EBITDA opportunity "is not a decade away, but rather a year away," Swinburne tells investors. Two contracts underwritten by Comcast (CMCSA) and Fox (FOXA) drive the bulk of its earnings growth and its financial outlook has no immediate exposure to ratings or cord-cutting, Swinburne added. While he trimmed his price target on WWE shares to $95 from $105 after bumping up his investment expectations for 2019, the analyst maintains an Overweight rating on the stock.
10/26/18
10/26/18
UPGRADE
Target $44

Outperform
Credit Suisse upgrades Comcast to Outperform on increased confidence in growth
As previously reported, Credit Suisse analyst Douglas Mitchelson upgraded Comcast to Outperform from Neutral, stating that he has increased confidence in its growth outlook given renewed momentum in broadband net adds, pricing upside, the deteriorating competitive positioning of satellite, wireless investment likely having peaked, and NBCU being well positioned. Additionally, he sees the potential for capital intensity to moderate meaningfully over time. Mitchelson increased his estimates above consensus and raised his price target on Comcast shares to $44 from $36.
CMCSK Comcast
$0.00

(0.00%)

10/03/18
STFL
10/03/18
NO CHANGE
Target $155
STFL
Buy
Trade Desk pullback due to misplaced concerns about Amazon, says Stifel
Stifel analyst John Egbert raised his mid- and long-term estimates for Trade Desk (TTD) citing momentum from new advertiser wins and the fact that platform spend and attach rates are benefiting from the recent New Wave product launch. He believes recent weakness in Trade Desk shares may be related to worries over online reports suggesting Amazon (AMZN) has discussed building a proprietary video ad serving product for its own streaming business, but sees these concerns as misplaced, Egbert added. Based on the available information, it seems like Amazon is focusing on video ad server technology, not a connected TV ad buying software tool, which would pit it against Trade Desk partners Comcast's (CMCSA) Freewheel and Google (GOOGL) Ad Manager, not Trade Desk itself, Egbert explains. He maintains a Buy rating on Trade Desk and raised his price target on the stock to $155 from $130.
BA Boeing
$369.34

-1.46 (-0.39%)

10/26/18
BERN
10/26/18
NO CHANGE
Target $440
BERN
Outperform
Boeing price target raised to $440 from $426 at Bernstein
Bernstein analyst Douglas Harnad raised his price target on Boeing to $440 from $426 following the company's "strong" Q3 results, telling investors in a research note that the main driver of Q3 was Boeing Commercial Airplanes performance, with margins above his estimates. Harnad does not expect the company's deals on the T-X trainer and the MQ-25 aircraft to derail an otherwise positive story at Boeing, as stock performance is dominated by BCA. Harnad has an Outperform rating on shares.
10/25/18
ADAM
10/25/18
NO CHANGE
Target $360
ADAM
Hold
Boeing price target raised to $360 from $350 at Canaccord
Canaccord analyst Ken Herbert raised his price target for Boeing to $360 from $350 following the company's quarterly results. In a research note to investors, Herbert says that while the results were better than expected and the stock significantly outperformed the broader market, he is maintaining a Hold rating. He continues to see pressure to the long-term margin rates, investment sentiment around the NMA, macro risk and new program development in both the commercial and defense markets, but acknowledges that free cash flow remains strong and Boeing has basically won what he views as the "must-win" BDS competitions.
10/25/18
JEFF
10/25/18
NO CHANGE
Target $420
JEFF
Buy
Boeing price target raised to $420 from $415 at Jefferies
In a post-earnings research note titled "When The Boeing is Good....," Jefferies analyst Sheila Kahyaoglu raised her price target for Boeing shares to $420 from $415. The analyst says the company's Q3 results highlighted many of the trends that support her Buy investment thesis, including productivity-driven earnings growth and cap deployment optionality.
10/24/18
ADAM
10/24/18
NO CHANGE
Target $350
ADAM
Hold
Boeing missed on earnings when backing out tax benefit, says Canaccord
Canaccord Genuity analyst Ken Herbert says that while Boeing missed earnings expectations this morning when excluding a 71c per share tax benefit, he continues to be impressed with its cash generation. Boeing increased its full year adjusted earnings per share guidance to $15.00, reflecting tax, upside in commercial airplanes, and the addition of KLX into the Services business, but kept its free cash flow outlook unchanged, Herbert tells investors in a post-earnings research note. The analyst, while continuing to see pressure to its long-term margin targets, believes investor concerns about tariffs and interest rates "have subsided to an extent," and that Boeing's "strong" free cash flow in the quarter is a positive catalyst for the stock. He keeps a Hold rating on the name with a $350 price target. Boeing in early trading is up 3%, or $10.16, to $360.21.
LMT Lockheed Martin
$313.24

4.73 (1.53%)

10/24/18
FBCO
10/24/18
NO CHANGE
Target $357
FBCO
Neutral
Lockheed Martin price target lowered to $357 from $368 at Credit Suisse
Credit Suisse analyst Robert Spingarn lowered his price target for Lockheed Martin to $357 from $368 following quarterly results. The analyst reiterates a Neutral rating on the shares.
10/24/18
GSCO
10/24/18
UPGRADE
Target $394
GSCO
Conviction Buy
Lockheed Martin upgraded to Conviction Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Noah Poponak upgraded Lockheed Martin to Buy and added the shares to his firm's Conviction List. He also raised his price target for the shares to $394 from $391.
10/24/18
10/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Noah Poponak raising his price target for the shares to $394 from $391. 2. Paccar (PCAR) upgraded to Overweight from Neutral at Piper Jaffray with analyst Alexander Potter saying Paccar's brands boasted the highest level of brand loyalty in his firm's survey of 743 U.S.-based fleets. 3. Morgan Stanley (MS) upgraded to Outperform from Market Perform at Wells Fargo with analyst Mike Mayo saying this means he now recommends 5 out of 5 of the largest U.S. wholesale banks. 4. 3D Systems (DDD) upgraded to Neutral from Underweight at Piper Jaffray with analyst Troy Jensen saying while Piper's Q3 survey "showed another poor performance" from 3D Systems' resellers, the company's "significant direct sales win" with Align Technology (ALGN) will continue to allow 3D Systems to report "impressive" year-over-year product growth for the next few quarters. 5. Lululemon (LULU) upgraded to Buy from Hold at Canaccord with analyst Camilo Lyon saying he recommends taking advantage of the recent 15% pullback as he believes the risk/reward is now skewed to the upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/18
FBCO
10/03/18
NO CHANGE
Target $368
FBCO
Neutral
Lockheed Martin price target raised to $368 from $340 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Lockheed Martin to $368 from $340 as his in-depth review of both the F-35 program and the broader business suggests that the bear case largely misses the mark. The analyst believes that Aeronautics and MFC will remain Lockheed's growth leaders over the next several years, and expects growth in Aeronautics to slow but remain positive beyond 2020 as rising F-35 sustainment revenues are only partially offset by C-130J headwinds and plateauing F-35 procurement quantities. RMS faces Black Hawk headwinds in the near-term, but growth should pick up in 2020 and beyond, he contends, adding that space should grow modestly in the near-term. The analyst reiterates a Neutral rating on the shares.
GD General Dynamics
$184.53

-0.06 (-0.03%)

10/24/18
STFL
10/24/18
NO CHANGE
Target $200
STFL
Hold
General Dynamics price target lowered to $200 from $210 at Stifel
Stifel analyst Joseph DeNardi lowered his price target for General Dynamics to $200 from $210 following mixed results as revenue guidance softens. The analyst views the supply chain issues affecting General Dynamics as fixable, while demand at Gulfstream and GD's defense business remains healthy. However, General Dynamics is going to be "treated differently by the market relative to its purer-play defense peers when cycle-related selloffs materialize like today," he contends. DeNardi reiterates a Hold rating on the shares.
10/25/18
WELS
10/25/18
NO CHANGE
Target $210
WELS
Outperform
General Dynamics price target lowered to $210 from $250 at Wells Fargo
Wells Fargo analyst Sam Pearlstein lowered his price target for General Dynamics to $210 from $250 due to the overall multiple compression in defense stocks. The analyst believes the stock's post-Q3 sell-off had several causes, including a slight EPS miss, a lower Aerospace backlog, and downward revenue revisions in three segments. Still, Pearlstein believes General Dynamics' core defense business is positioned for solid growth, while Gulfstream volumes should improve as soon as Q4. He reiterates and Outperform rating on the shares.
10/25/18
FBCO
10/25/18
NO CHANGE
Target $216
FBCO
Outperform
General Dynamics price target lowered to $216 from $229 at Credit Suisse
Credit Suisse analyst Robert Spingarn lowered his price target for General Dynamics to $216 from $229 as softer sales and questions on 2019 drive selloff in the shares. The analyst reiterates an Outperform rating on the shares.
09/21/18
09/21/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. UBS SAYS BUY AT&T: UBS analyst John Hodulik upgraded AT&T (T) to Buy and raised his price target for the shares to $38 from $33, noting that the stock is trading near all-time low valuations and at its widest valuation gap to Verizon (VZ). The Time Warner transaction and accounting changes "have compounded [other] issues, leading to a loss of visibility for investors," but his work indicates that AT&T will return to EBITDA growth in the second half of 2018, after a 6% decline in the first half, due to growth in Wireless and WarnerMedia as well as slower declines in Entertainment. JPMORGAN GOES TO BULL FROM BEAR ON NOVAVAX: JPMorgan analyst Eric Joseph double upgraded Novavax (NVAX) to Overweight from Underweight saying the risk/reward is favorable into the report of Prepare trial data in Q1 of 2019. The trial is assessing the efficacy of the company's RSV F Vaccine for infants via maternal immunization and the analyst believes the shares can hit a range of $2.00 to $2.25, he told investors. JPMORGAN SUGGESTS BEING SHORT COPART, LONG KAR: JPMorgan analyst Ryan Brinkman downgraded Copart (CPRT) to Underweight and lowered his price target for the shares to $47 from $48. The company reported softer than expected Q4 results this week but trades at "near record multiples" of earnings and EBITDA, Brinkman told investors. The analyst sees a potential pair trade in going long KAR Auction (KAR) shares, and short Copart shares, to capitalize on the "valuation disconnect." LOOP SETS $8.25 TARGET ON HARMONIC: Loop Capital analyst James Kisner initiated Harmonic (HLIT) with a Buy rating and $8.25 price target, saying he believes Harmonic can "drive robust revenue growth on its Cable Edge business as cable operators like Comcast (CMCSA, CMCSK) adopt its virtual CCAP/CMTS solution," and that the company's video business with stabilize. 'DON'T PANIC' OVER DOD PROPOSAL: Morgan Stanley analyst Rajeev Lalwani attributes the underperformance in Defense stocks over the last two days compared to the broader market to heightened concerns around a month old proposal from the Department of Defense to adjust progress and performance payments down to 50% from 80% of cost, which would effectively slow the timing of cash flow receipts closer to when a project is complete. He sees a number of reasons not to panic, mainly because he believes that the Administration will not move forward with a proposal industry-players will paint as being anti-business and anti-defense spending. Publicly-traded defense contractors include General Dynamics (GD), Huntington Ingalls (HII), L3 Technologies (LLL), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).

TODAY'S FREE FLY STORIES

TCEHY

Tencent

$0.00

(0.00%)

12:59
01/19/19
01/19
12:59
01/19/19
12:59
Periodicals
Tencent not the best opportunity out there right now, Barron's says »

After securing a billion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAESY

BAE Systems

$0.00

(0.00%)

12:53
01/19/19
01/19
12:53
01/19/19
12:53
Periodicals
Bae Systems will mount new charge, Barron's says »

Bae Systems has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,696.01

4.01 (0.24%)

, COST

Costco

$213.59

2.15 (1.02%)

12:50
01/19/19
01/19
12:50
01/19/19
12:50
Periodicals
Costco might be 'good buy' following 2018 pullback, Barron's says »

Part of what makes Costco…

AMZN

Amazon.com

$1,696.01

4.01 (0.24%)

COST

Costco

$213.59

2.15 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 31

    Jan

  • 20

    Feb

  • 03

    Mar

VNO

Vornado

$66.40

1.04 (1.59%)

, KRC

Kilroy Realty

$68.23

0.21 (0.31%)

12:45
01/19/19
01/19
12:45
01/19/19
12:45
Periodicals
Kilroy, Vornado Realty have 'solid' prospects, Barron's says »

Office REITs have been…

VNO

Vornado

$66.40

1.04 (1.59%)

KRC

Kilroy Realty

$68.23

0.21 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

GOLD

Barrick Gold

$11.78

-0.11 (-0.93%)

, GG

Goldcorp

$10.37

0.04 (0.39%)

12:41
01/19/19
01/19
12:41
01/19/19
12:41
Periodicals
Gold mining stocks 'an unalloyed bargain,' Barron's says »

Two multibillion-dollar…

GOLD

Barrick Gold

$11.78

-0.11 (-0.93%)

GG

Goldcorp

$10.37

0.04 (0.39%)

NEM

Newmont Mining

$31.77

0.15 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TECH

Bio-Techne

$163.24

1.16 (0.72%)

, A

Agilent

$71.93

1.16 (1.64%)

12:29
01/19/19
01/19
12:29
01/19/19
12:29
Periodicals
Rising demand benefiting Illumina, Thermo Fisher, Barron's says »

Healthy funding and…

TECH

Bio-Techne

$163.24

1.16 (0.72%)

A

Agilent

$71.93

1.16 (1.64%)

DHR

Danaher

$107.43

1.88 (1.78%)

TMO

Thermo Fisher

$240.72

2.55 (1.07%)

ILMN

Illumina

$312.66

2.53 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 29

    Jan

  • 29

    Jan

  • 30

    Jan

  • 30

    Jan

  • 05

    Feb

ATVI

Activision Blizzard

$48.64

1.26 (2.66%)

, EA

Electronic Arts

$92.50

3.19 (3.57%)

12:22
01/19/19
01/19
12:22
01/19/19
12:22
Periodicals
EA, Activision struggling to survive a Fortnite World, Barron's says »

Netflix (NFLX) delivered…

ATVI

Activision Blizzard

$48.64

1.26 (2.66%)

EA

Electronic Arts

$92.50

3.19 (3.57%)

NFLX

Netflix

$339.20

-14.02 (-3.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 05

    Feb

  • 12

    Feb

  • 25

    Feb

AIMT

Aimmune

$22.90

0.26 (1.15%)

, CELG

Celgene

$86.27

-0.32 (-0.37%)

09:01
01/19/19
01/19
09:01
01/19/19
09:01
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AIMT

Aimmune

$22.90

0.26 (1.15%)

CELG

Celgene

$86.27

-0.32 (-0.37%)

BIIB

Biogen

$337.46

-0.93 (-0.27%)

CMRE

Costamare

$4.97

0.09 (1.84%)

DAC

Danaos

$0.90

0.05 (5.88%)

DCIX

Diana Containerships

$0.90

-0.02 (-2.17%)

TGH

Textainer

$13.34

0.57 (4.46%)

NM

Navios Maritime

$2.73

-0.04 (-1.44%)

YRCM

Rogers Cantel

$0.00

(0.00%)

EXPD

Expeditors

$69.34

1.43 (2.11%)

LEN

Lennar

$44.11

-0.64 (-1.43%)

KBH

KB Home

$20.30

-0.28 (-1.36%)

PHM

PulteGroup

$26.58

-0.27 (-1.01%)

Z

Zillow

$33.93

0.35 (1.04%)

ZG

Zillow

$33.74

0.35 (1.05%)

RLGY

Realogy

$18.27

-0.155 (-0.84%)

RDFN

Redfin

$18.49

0.48 (2.67%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$16.78

0.16 (0.96%)

F

Ford

$8.59

0.23 (2.75%)

GM

General Motors

$38.63

0.35 (0.91%)

HMC

Honda

$29.77

0.22 (0.74%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$125.40

0.505 (0.40%)

VLKAY

Volkswagen

$0.00

(0.00%)

VC

Visteon

$76.43

4.85 (6.78%)

ADNT

Adient

$19.78

1.59 (8.74%)

AXL

American Axle

$14.62

0.45 (3.18%)

DLPH

Delphi Technologies

$15.94

0.44 (2.84%)

APTV

Aptiv

$72.91

1.77 (2.49%)

BWA

BorgWarner

$40.60

0.54 (1.35%)

LEA

Lear

$151.67

0.98 (0.65%)

TEN

Tenneco

$34.61

1.125 (3.36%)

MGA

Magna

$50.91

0.78 (1.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 25

    Jan

  • 29

    Jan

  • 29

    Jan

  • 31

    Jan

  • 06

    Feb

  • 07

    Feb

  • 14

    Feb

  • 19

    Feb

  • 25

    Apr

  • 18

    May

  • 28

    May

  • 24

    Jul

  • 23

    Oct

ASLN

Aslan Pharmaceuticals

$3.55

(0.00%)

, FPRX

Five Prime

$11.20

0.53 (4.97%)

04:55
01/19/19
01/19
04:55
01/19/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

ASCO GI 2019 Symposium…

ASLN

Aslan Pharmaceuticals

$3.55

(0.00%)

FPRX

Five Prime

$11.20

0.53 (4.97%)

KURA

Kura Oncology

$15.70

-0.06 (-0.38%)

ZLAB

Zai Lab

$25.98

-0.05 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
01/19/19
01/19
04:55
01/19/19
04:55
Conference/Events
Deutsche Bank to hold a conference »

17th Annual dbAccess…

TCCO

Technical Comm Corp

$2.61

-0.19 (-6.79%)

18:02
01/18/19
01/18
18:02
01/18/19
18:02
Hot Stocks
Technical Comm Corp reports notice of failure to satisfy Nasdaq rule »

Technical Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$6.19

0.455 (7.93%)

17:38
01/18/19
01/18
17:38
01/18/19
17:38
Periodicals
Snap exec fired due to undisclosed relationship with consultant, Cheddar says »

Snap's global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 05

    Feb

  • 03

    Mar

SSW

Seaspan

$9.16

0.16 (1.78%)

17:33
01/18/19
01/18
17:33
01/18/19
17:33
Syndicate
Breaking Syndicate news story on Seaspan »

Seaspan files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXT

Textron

$49.38

0.75 (1.54%)

17:30
01/18/19
01/18
17:30
01/18/19
17:30
Hot Stocks
Textron subsidiary awarded $439.56M government contract modification »

Bell Helicopter Textron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

TAC

TransAlta

$4.91

0.04 (0.82%)

17:28
01/18/19
01/18
17:28
01/18/19
17:28
Hot Stocks
Mangrove Partners reports 9.4% passive stake in TransAlta »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDS

Telephone and Data

$36.27

0.42 (1.17%)

17:27
01/18/19
01/18
17:27
01/18/19
17:27
Hot Stocks
Telephone and Data's Meyers sells 80,465 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$137.24

2.59 (1.92%)

17:03
01/18/19
01/18
17:03
01/18/19
17:03
Syndicate
Breaking Syndicate news story on GW Pharmaceuticals »

GW Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCSC

Fibrocell Science

$2.03

0.03 (1.50%)

16:55
01/18/19
01/18
16:55
01/18/19
16:55
Syndicate
Breaking Syndicate news story on Fibrocell Science »

Fibrocell Science files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLC

EnLink Midstream

$11.75

0.4 (3.52%)

, ENLK

EnLink Midstream Partners

$13.58

0.51 (3.90%)

16:49
01/18/19
01/18
16:49
01/18/19
16:49
Conference/Events
EnLink Midstream Partners to hold a special shareholder meeting »

Special Shareholder…

ENLC

EnLink Midstream

$11.75

0.4 (3.52%)

ENLK

EnLink Midstream Partners

$13.58

0.51 (3.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

FDX

FedEx

$176.97

3.72 (2.15%)

16:49
01/18/19
01/18
16:49
01/18/19
16:49
Hot Stocks
FedEx establishes voluntary buyout program for U.S. workers »

FedEx said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 31

    Jan

  • 03

    Mar

  • 19

    Mar

  • 01

    Apr

  • 02

    Apr

ENLK

EnLink Midstream Partners

$13.58

0.51 (3.90%)

, ENLC

EnLink Midstream

$11.75

0.4 (3.52%)

16:48
01/18/19
01/18
16:48
01/18/19
16:48
Conference/Events
EnLink Midstream Companies to hold a special shareholder meeting »

Special Shareholder…

ENLK

EnLink Midstream Partners

$13.58

0.51 (3.90%)

ENLC

EnLink Midstream

$11.75

0.4 (3.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

MKL

Markel

$1,067.03

13.52 (1.28%)

16:36
01/18/19
01/18
16:36
01/18/19
16:36
Hot Stocks
Markel says Anthony Belisle, Alissa Fredricks no longer with company »

Markel Corporation said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NILSY

Norilsk Nickel

$0.00

(0.00%)

16:35
01/18/19
01/18
16:35
01/18/19
16:35
Downgrade
Norilsk Nickel rating change at Goldman Sachs »

Norilsk Nickel downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$130.65

1.54 (1.19%)

, ABBV

AbbVie

$89.51

2.28 (2.61%)

16:33
01/18/19
01/18
16:33
01/18/19
16:33
Hot Stocks
AbbVie: Phase 3 study of ibrutinib did not meet primary endpoint »

AbbVie (ABBV) announced…

JNJ

Johnson & Johnson

$130.65

1.54 (1.19%)

ABBV

AbbVie

$89.51

2.28 (2.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 27

    Jan

  • 28

    Jan

  • 18

    Feb

  • 18

    May

FOMX

Foamix

$3.70

-0.14 (-3.65%)

16:32
01/18/19
01/18
16:32
01/18/19
16:32
Conference/Events
Foamix to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.